Anthropic plans to expand its growing presence in life sciences by investing further in knowledge, talent, partnerships, and ...

Scaling the science into any kind of business “is just really tough, but scaling a biotechnology company in South Africa is ...

Closing the execution gap is one of the greatest opportunities biopharma has today to enhance resilience and unlock the full ...

The collective activity of all six genes, which the researchers called the PHFScore, divided patients into groups with ...

An entity of Swedish private equity firm EQT has agreed to acquire Qiagen for €10.8 billion (about $12.1 billion) cash, both said today, in a deal that would take private the global life-sciences ...

The University of Washington School of Medicine Institute for Protein Design (IPD) has partnered with Nvidia to develop an ...

ASHG President Susan Slaugenhaupt, PhD, opened the society’s Montreal meeting with a heartfelt address of hope, leadership, ...

In this GEN webinar, our expert speaker Josh Wheeler, MD, PhD, will discuss a biology-first, interpretable AI approach to ...

Pluristyx leaders outline how better starting materials, automation, and process control can scale iPSC manufacturing.

Gene therapy firms need to consider patients when choosing a viral vector production method, say researchers behind new economic analysis.

Catalytic reactive-hydrogen membranes capture and break down six PFAS in water, achieving up to 96% removal and 83% defluorination in a 58-day test.

Roche and Hansoh Pharmaceutical Group have launched their second collaboration focused on developing cancer-fighting antibody-drug conjugates (ADCs), a partnership that could generate more than $15 ...